Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00432679
What this trial is testing

BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 149
Testing effectiveness (Phase 2)Study completedNCT01969318
What this trial is testing

Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 120
Not applicableLooking for participantsNCT07701590
What this trial is testing

CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs

Who this might be right for
Wound, FootDiabetic Foot Ulcer (DFU)Venus Leg Ulcer
Capsicure, LLC 147
Post-approval studies (Phase 4)Study completedNCT00060918
What this trial is testing

Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension

Who this might be right for
Hypertension
GlaxoSmithKline 1,210
Large-scale testing (Phase 3)Not Yet RecruitingNCT07241897
What this trial is testing

DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes

Who this might be right for
Ischemic StrokeDiabete Mellitus
Second Affiliated Hospital of Soochow University 312
Large-scale testing (Phase 3)Study completedNCT00710424
What this trial is testing

Sativex® for Pain Relief Due to Diabetic Neuropathy

Who this might be right for
PainDiabetic Neuropathy
Jazz Pharmaceuticals 297
Testing effectiveness (Phase 2)Looking for participantsNCT07812090
What this trial is testing

A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema (DME)
BioAge Labs, Inc. 180
Not applicableLooking for participantsNCT07173062
What this trial is testing

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

Who this might be right for
StrokeCoronary Arterial Disease (CAD)Myocardial Infarction (MI)+4 more
Universidade do Porto 150
Large-scale testing (Phase 3)Study completedNCT02577003
What this trial is testing

Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 143
Post-approval studies (Phase 4)Study completedNCT00754403
What this trial is testing

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 312
Large-scale testing (Phase 3)Study completedNCT01646320
What this trial is testing

Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 320
Testing effectiveness (Phase 2)Study completedNCT01756703
What this trial is testing

Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 67
Testing effectiveness (Phase 2)Study completedNCT01169090
What this trial is testing

A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

Who this might be right for
Type 2 Diabetes
Kowa Research Institute, Inc. 620
Testing effectiveness (Phase 2)Study completedNCT01240759
What this trial is testing

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Shionogi 218
Large-scale testing (Phase 3)Study completedNCT02630706
What this trial is testing

Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 506
Large-scale testing (Phase 3)Study completedNCT01370616
What this trial is testing

Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)

Who this might be right for
Infection; Diabetic Foot
Merck Sharp & Dohme LLC 565
Testing effectiveness (Phase 2)WithdrawnNCT01556152
What this trial is testing

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

Who this might be right for
Painful Diabetic Neuropathy
Glenmark Pharmaceuticals Ltd. India
Testing effectiveness (Phase 2)Study completedNCT00845858
What this trial is testing

Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis

Who this might be right for
GastroparesisDiabetic GastroparesisDiabetes+2 more
Evoke Pharma 287
Large-scale testing (Phase 3)Study completedNCT04807348
What this trial is testing

Chiglitazar Added to Metformin for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 533
Large-scale testing (Phase 3)Study completedNCT00968708
What this trial is testing

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Acute Coronary Syndrome
Takeda 5,380
Next Page